Skip to content
OpenCapital
Get started

Hitachi HIT Cash & Equivalents

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$4.95B+16.5%
CVS Health logo
CVS HealthCVS
$9.77B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Elevance Health logo
Elevance HealthELV
$9.66B+28.8%
Cigna logo
CignaCI
$7.04B-15.5%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$142.03M-42.4%

Other financials

Income statement

See full
Revenue$8.8M+9.4%
Gross profit$4.5M-15.8%
Net income-$1.6M-419%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Total debt$121.6K-36.2%
Total equity$21.6M+52.6%
Total assets$29.0M+35.8%

Cash flow

See full
Operating cash flow-$3.3M-729%

Valuation

See full
Market cap$66.21M+51.3%
Enterprise value$56.01M+56.5%
P/S1.9×+0.3×

Profitability

See full
Gross margin58.9%-15.5pp
Net margin9.3%—

Returns & leverage

See full
Return on equity105.4%—
Debt / equity0×0.0×
Current ratio3.1×+0.8×

Where this comes from

Reported directly by Hitachi in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Hitachi’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hitachi's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hitachi's cash & equivalents?
Hitachi (HIT) reported cash & equivalents of $10.33M in Q1 2026.
How has Hitachi's cash & equivalents changed year-over-year?
Hitachi's cash & equivalents increased by 36.3% year-over-year, from $7.58M to $10.33M.
What is the long-term trend for Hitachi's cash & equivalents?
Over 3 years (2022 to 2025), Hitachi's cash & equivalents has grown at a 72.7% compound annual growth rate (CAGR), from $1.49M to $7.67M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.